Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy
Cancer Chemotherapy and Pharmacology, 09/23/09
Clyburn RD et al. – This is the first detailed study to show that an increased anti–tumour effect is generated when doxorubicin and zoledronic acid are given in sequence in both hormone–sensitive and insensitive prostate cancer cells in vitro. The results suggest that combined treatment with these agents is superior to single agent therapy, and should be explored in a tumour model of prostate cancer.
Related Articles
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09
Relevance Score: 92%
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Cardiovascular and Interventional Radiology, 11/17/09
Relevance Score: 87%
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
Annals of Oncology, 10/29/09
Relevance Score: 87%
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma
Investigational New Drugs, 10/23/09
Relevance Score: 87%
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Journal of Molecular and Cellular Cardiology, 10/20/09
Relevance Score: 84%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/20/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas
Annals of Diagnostic Pathology, 12/20/09
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/19/09
Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
Cancer Research, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


